RAD51 and renal cell carcinoma: DNA damage repair biomarkers, p-DNA-PK and Rad51, were reduced by knockdown of PDIA6, suggesting that PDIA6 promoted DNA damage repair to enhance the resistance of renal cell carcinoma to imatinib.